drugset / Trial / NCT03041285
Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer
Non-randomizedSequentialOpen-labelTreatment
Summary
The aim of the study is to determine the toxicity of Idronoxil (NOX66) when used in combination with palliative radiotherapy for metastatic prostate cancer
Timeline
- Start
- 2017-08-31
- Primary completion
- 2019-09-17
- Completion
- 2019-09-17
Outcome
Outcome not reported
Stopped: “have difficulty finding eligible participants”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | idronoxil | Small molecule | 400 mg | — |
| Subject | idronoxil | Small molecule | 800 mg | — |